O
REUN

OrbiMed’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

OrbiMed’s Portfolio REUN Stock Details REUN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-115,386
Closed -$762K – 154
2022
Q1 		$762K Sell
115,386
-192,308
-62% -$1.6M 0.01% 138
2021
Q4 		$3.72M Hold
307,694
– – 0.05% 141
2021
Q3 		$7M Buy
+307,694
New +$7.74M 0.08% 145

Other funds holding REUN

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
OPOWM
One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

OrbiMed's REUN Position: Q2 2022 in Review

OrbiMed sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q2 2022, closing a stake of 115,386 shares — an estimated $762K sold.

OrbiMed first reported a position in REUN in Q3 2021 and held it in 3 quarters. The position peaked at $7M in Q3 2021. 30 funds tracked by Wall St. Rank hold REUN as of Q2 2022.

  • OrbiMed reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q2 2022 after selling out during the quarter.
  • OrbiMed sold 115,386 Reunion Neuroscience Inc. Common Shares shares in Q2 2022, an estimated $762K.
  • OrbiMed first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 3 quarters.
  • OrbiMed's Reunion Neuroscience Inc. Common Shares position peaked at $7M in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q2 2022.

Based on OrbiMed's 13F filing for Q2 2022, filed 15 Aug 2022.